Procept BioRobotics Leadership Change
PROCEPT BioRobotics Corporation has expanded its board of directors from nine to ten members and appointed Dr. Michael Mack as a new independent Class II director, effective October 2, 2026. Dr. Mack, a highly published cardiac surgeon and healthcare executive, will serve until the 2029 annual meeting of stockholders. He will receive compensation consistent with the company's existing non-employee director program.